Since the FDA approval and release of Vuity in late 2021, physicians and patients now have a new option for presbyopia treatment.
Vuity (Allergan) delivers a proprietary formulation of pilocarpine 1.25% to the eye to induce a pinhole effect, thus improving near vision.
Healio/OSN spoke with Nandini Venkateswaran, MD, about finding the right patients for Vuity and what other options she uses in patients with presbyopia.
Healio/OSN: Which patients are ideal candidates for Vuity?
Venkateswaran: In my practice, I am finding that the ideal patients for Vuity are probably early to moderate presbyopes,